219 related articles for article (PubMed ID: 19420766)
1. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
2. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
3. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
4. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
Sato Y; Hatakeyama H; Harashima H
Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
[TBL] [Abstract][Full Text] [Related]
5. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
[TBL] [Abstract][Full Text] [Related]
8. An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide.
Khalil IA; Harashima H
Int J Pharm; 2018 Mar; 538(1-2):179-187. PubMed ID: 29341911
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
10. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
Toriyabe N; Hayashi Y; Harashima H
Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
[TBL] [Abstract][Full Text] [Related]
11. PEGylation of the GALA Peptide Enhances the Lung-Targeting Activity of Nanocarriers That Contain Encapsulated siRNA.
Santiwarangkool S; Akita H; Nakatani T; Kusumoto K; Kimura H; Suzuki M; Nishimura M; Sato Y; Harashima H
J Pharm Sci; 2017 Sep; 106(9):2420-2427. PubMed ID: 28483420
[TBL] [Abstract][Full Text] [Related]
12. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
14. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
15. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
[TBL] [Abstract][Full Text] [Related]
17. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
El-Sayed A; Masuda T; Akita H; Harashima H
J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
[TBL] [Abstract][Full Text] [Related]
18. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
19. Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver.
Yamauchi J; Hayashi Y; Kajimoto K; Akita H; Harashima H
Biol Pharm Bull; 2010; 33(5):926-9. PubMed ID: 20460780
[TBL] [Abstract][Full Text] [Related]
20. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
